Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

SKYE Relative to the S&P 500

SKYE Relative to the Sector

Seasonal Chart Analysis

Analysis of the Skye Bioscience Inc. (NASD:SKYE) seasonal charts above shows that a Buy Date of December 3 and a Sell Date of March 22 has resulted in a geometric average return of 32.8% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 92.99% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

To download SKYE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: SKYE